Intravascular large B-cell lymphoma: The heterogeneous clinical manifestations of its classical and hemophagocytosis-related forms

Haematologica

Volumn 92, Issue 4, 2007, Pages 434-436

  Nakamura, Shigeo ^a   Murase, Takuhei ^b   Kinoshita, Tomohiro ^c  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b Nishio Municipal Hospital   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; EDITORIAL; ERYTHROPHAGOCYTOSIS; GERMINAL CENTER; HUMAN; IMMUNOPHENOTYPING; INTRAVASCULAR LARGE B CELL LYMPHOMA; MALIGNANT HISTIOCYTOSIS; MEDICAL DOCUMENTATION; MULTIPLE MYELOMA; PANCYTOPENIA; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; WORLD HEALTH ORGANIZATION; ASIAN; CAUCASIAN; CLASSIFICATION; DISEASE COURSE; ETHNOLOGY; FEMALE; FORECASTING; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTIOCYTIC LYMPHOMA; JAPAN; MALE; NOTE; PATHOLOGY; SKIN TUMOR; VASCULAR TUMOR;

ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORECASTING; HUMANS; JAPAN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA, LARGE-CELL; MALE; PROGNOSIS; SKIN NEOPLASMS; VASCULAR NEOPLASMS;

EID: 34547673296     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11372     Document Type: Editorial

References (17)

1. Gatter KC, Warnke RA. Intravascular large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization: Pathology and Genetics of Tumors of Heamatopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. p. 177-8.
2. Pfleger VL, Tappeiner J. Zur Kenntnis der systemisierten Endotheliomatose der cutanen Blutgef(ass)e (Reticuloendotheliose?). Der Hautarzt 1959;10:363-9.
3. Murase T, Nakamura S, Tashiro K, Suchi T, Hiraga J, Hayasaki N, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br J Haematol 1997;99:656-64.
4. Murase T, Nakamura S, Kawauchi K, Matsuzaki H, Sakai C, Inaba T, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000;111:826-34.
5. Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004;127:173-83.
6. Wu S-J, Chou W-C, Ko B-S, Tien H-F. Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma. Haematologica 2007;92:141-2
7. Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru JI, et al. Intravascular large B-cell lymphoma (IVL-BCL): a clinicopathologic study or 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007;109:478-85.
8. Majluf-Cruz A, Sosa-Camas R, Perez-Ramirez O, Rosas-Cabral A, Vargas-Vorackova F, Labardini-Mendez J. Hemophagocytic syndrome associated with hematological neoplasias. Leuk Res 1998;22:893-8.
9. Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001; 74: 209-13.
10. Dufau JP, Le Tourneau A, Molina T, Le Houcq M, Claessens YE, Rio B, et al. Intravascular large B-cell lymphoma with bone marrow involvement at presentation and haemophagocytic syndrome: two Western cases in favour of a specific variant. Histopathology 2000;37:509-12.
11. Bogomolski-Yahalom V, Lossos IS, Okun E, Sherman Y, Lossos A, Polliack A. Intravascular lymphomatosis-an indolent or aggressive entity? Leuk Lymphoma 1998;29: 585-93.
12. Ferreri AJM, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, et al. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographic regions. Hematologica 2007;92:485-91.
13. Hans CP, Weisenburger DD, Greiner TC, Gascoyne D, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
14. Kanda M, Suzumiya J, Ohshima K, Tamura K, Kikuchi M. Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies. Leuk Lymphoma 1999;34:569-80.
15. + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 2002;99:815-21.
16. Rubenstein JL, Fridyland J, Shen A, Aldape K, Grinzinger D, Batchelor T, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood 2006;107:3176-23.
17. Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, et al. Lack of CD 29 (β1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000;31:220-6.